Kolovou Genovefa D, Anagnostopoulou Katherine K, Salpea Klelia D, Daskalopoulou Stella S, Mikhailidis Dimitri P
Cardiology Department, Onassis Cardiac Surgery Center, Athens, Greece.
Curr Drug Targets. 2007 Apr;8(4):551-60. doi: 10.2174/138945007780362809.
Several studies showed that postprandial plasma triglyceride (TG) concentrations are higher in patients with coronary heart disease. TG-rich lipoprotein remnants accumulated in the postprandial state are involved in atherogenesis and in events leading to thrombosis. Lipid lowering drugs, such as 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors (statins) are of significant benefit in the primary and secondary prevention of atherosclerosis. Statins can decrease total cholesterol and low density lipoprotein cholesterol as well as TG concentrations and improve postprandial lipoprotein metabolism. Since abnormal postprandial lipemia is associated with pathological conditions, its treatment is relevant. This review considers the effect of statins on postprandial lipemia.
多项研究表明,冠心病患者餐后血浆甘油三酯(TG)浓度较高。餐后状态下积累的富含TG的脂蛋白残粒参与动脉粥样硬化的发生以及导致血栓形成的过程。降脂药物,如3-羟基-3-甲基戊二酰辅酶A还原酶抑制剂(他汀类药物)在动脉粥样硬化的一级和二级预防中具有显著益处。他汀类药物可降低总胆固醇、低密度脂蛋白胆固醇以及TG浓度,并改善餐后脂蛋白代谢。由于异常的餐后血脂异常与病理状况相关,因此对其进行治疗具有重要意义。本综述探讨了他汀类药物对餐后血脂异常的影响。